(Q39522892)

12 September 2017

title

Licofelone-nitric oxide donors as anticancer agents (English)

1 reference

12 September 2017

Wukun Liu

1

1 reference

12 September 2017

Jinpei Zhou

2

1 reference

12 September 2017

Yinglin Liu

3

1 reference

12 September 2017

Haoran Liu

4

1 reference

12 September 2017

Kerstin Bensdorf

5

1 reference

12 September 2017

Cancheng Guo

6

1 reference

12 September 2017

Ronald Gust

7

1 reference

12 September 2017

publication date

16 June 2011

1 reference

Archiv der Pharmazie - Chemistry in Life Sciences

12 September 2017

published in

1 reference

12 September 2017

volume

344

1 reference

12 September 2017

issue

8

1 reference

12 September 2017

page(s)

487-493

1 reference

Nitric oxide donors: chemical activities and biological applications

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

NO news is not necessarily good news in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Targeting nitric oxide for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Chemosensitization of cancer by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

NSAIDs and breast cancer: a possible prevention and treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Cyclooxygenase-1/2 (COX-1/COX-2) and 5-lipoxygenase (5-LOX) inhibitors of the 6,7-diaryl-2,3-1H-dihydropyrrolizine type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Relationship between anticancer activity and stereochemistry of saldach ligands and their iron(III) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Porphyrins containing nitric oxide donors: Synthesis and cancer cell-oriented NO release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: "nitric oxide donor" agents for evaluation as anticancer and antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FARDP.201000397

21 January 2018

Identifiers

DOI

10.1002/ARDP.201000397

1 reference

12 September 2017

1 reference